Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Tapentadol Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Tapentadol Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 100 mg Tablets
      • 1.3.3 75 mg Tablets
      • 1.3.4 50 mg Tablets
    • 1.4 Market Segment by Application
      • 1.4.1 Global Tapentadol Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Pharmacy
      • 1.4.5 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Tapentadol Market Size
      • 2.1.1 Global Tapentadol Revenue 2014-2025
      • 2.1.2 Global Tapentadol Sales 2014-2025
    • 2.2 Tapentadol Growth Rate by Regions
      • 2.2.1 Global Tapentadol Sales by Regions 2014-2019
      • 2.2.2 Global Tapentadol Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Tapentadol Sales by Manufacturers
      • 3.1.1 Tapentadol Sales by Manufacturers 2014-2019
      • 3.1.2 Tapentadol Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Tapentadol Revenue by Manufacturers (2014-2019)
      • 3.2.2 Tapentadol Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Tapentadol Market Concentration Ratio (CR5 and HHI)
    • 3.3 Tapentadol Price by Manufacturers
    • 3.4 Key Manufacturers Tapentadol Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Tapentadol Market
    • 3.6 Key Manufacturers Tapentadol Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 100 mg Tablets Sales and Revenue (2014-2019)
      • 4.1.2 75 mg Tablets Sales and Revenue (2014-2019)
      • 4.1.3 50 mg Tablets Sales and Revenue (2014-2019)
    • 4.2 Global Tapentadol Sales Market Share by Type
    • 4.3 Global Tapentadol Revenue Market Share by Type
    • 4.4 Tapentadol Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Tapentadol Sales by Application

    6 United States

    • 6.1 United States Tapentadol Breakdown Data by Company
    • 6.2 United States Tapentadol Breakdown Data by Type
    • 6.3 United States Tapentadol Breakdown Data by Application

    7 European Union

    • 7.1 European Union Tapentadol Breakdown Data by Company
    • 7.2 European Union Tapentadol Breakdown Data by Type
    • 7.3 European Union Tapentadol Breakdown Data by Application

    8 China

    • 8.1 China Tapentadol Breakdown Data by Company
    • 8.2 China Tapentadol Breakdown Data by Type
    • 8.3 China Tapentadol Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Tapentadol Breakdown Data by Company
    • 9.2 Rest of World Tapentadol Breakdown Data by Type
    • 9.3 Rest of World Tapentadol Breakdown Data by Application
    • 9.4 Rest of World Tapentadol Breakdown Data by Countries
      • 9.4.1 Rest of World Tapentadol Sales by Countries
      • 9.4.2 Rest of World Tapentadol Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Johnson & Johnson Pharmaceutical Research & Development
      • 10.1.1 Johnson & Johnson Pharmaceutical Research & Development Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Tapentadol
      • 10.1.4 Tapentadol Product Introduction
      • 10.1.5 Johnson & Johnson Pharmaceutical Research & Development Recent Development
    • 10.2 IPCA Laboratories
      • 10.2.1 IPCA Laboratories Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Tapentadol
      • 10.2.4 Tapentadol Product Introduction
      • 10.2.5 IPCA Laboratories Recent Development
    • 10.3 Lupin Laboratories
      • 10.3.1 Lupin Laboratories Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Tapentadol
      • 10.3.4 Tapentadol Product Introduction
      • 10.3.5 Lupin Laboratories Recent Development
    • 10.4 Ranbaxy Laboratories
      • 10.4.1 Ranbaxy Laboratories Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Tapentadol
      • 10.4.4 Tapentadol Product Introduction
      • 10.4.5 Ranbaxy Laboratories Recent Development
    • 10.5 Aristo Pharmaceuticals
      • 10.5.1 Aristo Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Tapentadol
      • 10.5.4 Tapentadol Product Introduction
      • 10.5.5 Aristo Pharmaceuticals Recent Development
    • 10.6 Cadila Pharmaceuticals
      • 10.6.1 Cadila Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Tapentadol
      • 10.6.4 Tapentadol Product Introduction
      • 10.6.5 Cadila Pharmaceuticals Recent Development
    • 10.7 Tirupati Medicare
      • 10.7.1 Tirupati Medicare Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Tapentadol
      • 10.7.4 Tapentadol Product Introduction
      • 10.7.5 Tirupati Medicare Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Tapentadol Sales Channels
      • 11.2.2 Tapentadol Distributors
    • 11.3 Tapentadol Customers

    12 Market Forecast

    • 12.1 Global Tapentadol Sales and Revenue Forecast 2019-2025
    • 12.2 Global Tapentadol Sales Forecast by Type
    • 12.3 Global Tapentadol Sales Forecast by Application
    • 12.4 Tapentadol Forecast by Regions
      • 12.4.1 Global Tapentadol Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Tapentadol Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration.
      North America is the largest market for tapentadol followed by Europe and Asia Pacific.
      In 2019, the market size of Tapentadol is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tapentadol.

      This report studies the global market size of Tapentadol, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Tapentadol sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Johnson & Johnson Pharmaceutical Research & Development
      IPCA Laboratories
      Lupin Laboratories
      Ranbaxy Laboratories
      Aristo Pharmaceuticals
      Cadila Pharmaceuticals
      Tirupati Medicare
      ...

      Market Segment by Product Type
      100 mg Tablets
      75 mg Tablets
      50 mg Tablets

      Market Segment by Application
      Hospital
      Clinic
      Pharmacy
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Tapentadol status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Tapentadol manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Tapentadol are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now